|
|
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 1 |
First Approval Ctry. / Loc.- |
First Approval Date- |
A Phase 1 Randomized, Single-Blind, Three-Arm, Staggered Parallel Study to Assess the Safety, Tolerability, and Pharmacokinetics of Atorvo+™ in Healthy Adult Participants
A Phase 1 study will assess the safety, tolerability, and pharmacokinetics of Atorvo+™ in healthy adult participants.
.
100 Clinical Results associated with Indication Bioscience LLC
0 Patents (Medical) associated with Indication Bioscience LLC
100 Deals associated with Indication Bioscience LLC
100 Translational Medicine associated with Indication Bioscience LLC